CIRM Funded Clinical Trials

Phase 1 Study of Autologous E-SYNC T Cells in Adult Participants with EGFRvIII+ Glioblastoma

Disease Area:
CIRM Grant:
CLIN2-15562 (Active)
Award Value:
Trial Sponsor:
University of California, San Francisco
Trial Stage:
Phase 1
Trial Status:
Targeted Enrollment:

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website